๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The role of progestins and progesterone receptors in the treatment of breast cancer

โœ Scribed by Scot M. Sedlacek; Kathryn B. Horwitz

Book ID
119481541
Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
780 KB
Volume
44
Category
Article
ISSN
0039-128X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Progesterone antagonists and progesteron
Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer
โœ Jan G.M. Klijn; Buddy Setyono-Han; John A. Foekens ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 95 KB

Progesterone antagonists (PAs) (antiprogestins) or progesterone receptor modulators (PRMs) form an interesting category of new hormonal agents in the treatment of breast cancer. In vitro, antiproliferative effects of different PAs are mainly observed in estrogen-stimulated growth of PR-positive tumo

The role of progesterone receptors in th
The role of progesterone receptors in the management of advanced breast cancer
โœ Norman D. Bloom; Ellis H. Tobin; Barbara Schreibman; George A. Degenshein ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 456 KB ๐Ÿ‘ 3 views

The identification of steroid receptors in human breast cancer tissues has provided biochemical markers to predict hormone responsiveness. Analysis of tumors from 328 patients for the estrogen receptor protein (ERP) revealed significant levels in 225 patients (68%). Fifty-five patients with advanced